ARTICLE | Clinical News
CMV gB/MF59: Phase II data
March 23, 2009 7:00 AM UTC
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) published data in the New England Journal of Medicine showing that treatment with CMV gB/MF59 resulted in a significa...